Odyssey Therapeutics, Inc. is projected to rise to $30.97 by 2027, a +64% move from its current price of $18.93. ODTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $18.41 | $18.95 | $19.50 | +0.09% |
| Aug 3 | $18.21 | $18.96 | $19.75 | +0.18% |
| Aug 4 | $18.06 | $18.98 | $19.95 | +0.27% |
| Aug 5 | $17.94 | $19.00 | $20.12 | +0.36% |
| Aug 6 | $17.83 | $19.02 | $20.28 | +0.45% |
| Aug 7 | $17.74 | $19.03 | $20.42 | +0.54% |
| Aug 8 | $17.65 | $19.05 | $20.56 | +0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.65 | $19.05 | $20.56 | +0.63% |
| Week 2 | $17.21 | $19.17 | $21.35 | +1.27% |
| Week 3 | $16.91 | $19.29 | $22.01 | +1.90% |
| Week 4 | $16.67 | $19.41 | $22.60 | +2.55% |
| Week 5 | $16.48 | $19.53 | $23.16 | +3.19% |
| Week 6 | $16.31 | $19.66 | $23.69 | +3.84% |
| Week 7 | $16.17 | $19.78 | $24.20 | +4.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on medicines for autoimmune and inflammatory diseases. Its pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of IRF5; OD-003, a protein therapeutic designed to agonize tumor necrosis factor receptor 2 selectively on Treg; a TSLP/IL-33 bispecific antagonist; an oral small molecule interleukin-1 receptor–associated kinase 4 scaffolding inhibitor; and a small molecule inhibitor of IRF5.
The company was incorporated in 2021 and is headquartered in Boston, Massachusetts.
Odyssey Therapeutics, Inc. trades under the symbol ODTX and is currently priced at $18.22. Its market cap is $875.13M and it is ranked 2618. The stock’s near-term price action is supported by a defined 30-day range and key technical levels, with a bullish longer-term outlook implied by the forecast sequence.
A major floor 24.2% below — a decisive break under it would weaken the trend.
The nearest floor, 17.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.7% away) — a breakout level to watch.
A major ceiling 12.9% above — clearing it would confirm fresh momentum.
Key ODTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ODTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $18.57 | Buy | $18.54 | Buy |
| MA 10 | $18.36 | Buy | $18.30 | Buy |
| MA 20 | $17.60 | Buy | $17.99 | Buy |
| MA 50 | $17.55 | Buy | $17.59 | Buy |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.40 | Neutral |
| Stoch RSI (14) | 81.08 | Sell |
| CCI (20) | 115.66 | Buy |
| Williams %R (14) | -5.08 | Info |
| MACD (12,26,9) | 0.12 | Buy |
| ROC (12) | 9.74 | Buy |
| Bollinger %B (20,2) | 0.85 | Neutral |
| Stochastic %K (14) | 94.92 | Sell |
| TRIX (15) | 0.17 | Buy |
| Awesome (5,34) | 0.79 | Buy |
| Ultimate (7,14,28) | 55.29 | Neutral |
| Momentum (10) | 1.32 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 18.50 | Buy |
| ADX (14) | 11.90 | Neutral |
| ATR (14) | 0.50 | Info |
The 30-day range is $14.95 to $22.20, indicating a broad trading band. The RSI (14 days) is 60, and the price is positioned around the 50-day simple moving average of $17.38, suggesting a constructive near-term bias. Key levels to watch are a support at $15.56 and a resistance at $19.07, consistent with a bullish tilt in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.56 | $18.93 | $29.08 | 0% | Neutral | |
| $23.40 | $30.97 | $44.04 | +64% | Bullish | |
| $28.34 | $39.35 | $59.11 | +108% | Bullish | |
| $32.95 | $47.61 | $74.58 | +151% | Bullish | |
| $36.89 | $55.25 | $89.63 | +192% | Bullish | |
| $37.44 | $57.96 | $96.90 | +206% | Bullish | |
| $43.43 | $69.36 | $119.10 | +266% | Bullish | |
| $53.68 | $88.30 | $155.33 | +366% | Bullish | |
| $62.85 | $106.38 | $191.29 | +462% | Bullish | |
| $72.71 | $126.51 | $232.15 | +568% | Bullish | |
| $103.26 | $204.63 | $408.27 | +981% | Bullish | |
| $208.27 | $462.81 | $1,039.86 | +23.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $15.56 | $18.93 | $24.52 | +0.00% |
| September 2026 | $17.11 | $20.60 | $25.74 | +8.83% |
| October 2026 | $16.88 | $20.55 | $26.10 | -0.27% |
| November 2026 | $17.34 | $21.29 | $27.40 | +3.62% |
| December 2026 | $18.04 | $22.33 | $29.08 | +4.91% |
Click any year to see its month-by-month ODTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Odyssey Therapeutics, Inc.'s 2026 outlook centres on $18.93, within a $15.56 to $29.08 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ODTX could reach as high as $44.04, with a base case around $30.97 and support toward $23.40 — roughly +64% from $18.93. Buyers look set to stay in control over this stretch.
Expect ODTX to range from $28.34 to $59.11 through 2028. The $39.35 average target implies a +108% move from current prices. That is up +27% on the projected 2027 average. Momentum favours further upside here.
The ODTX price prediction for 2029 points to an average of $47.61 (low $32.95, high $74.58) — a potential gain of +151% on today's $18.93. Buyers look set to stay in control over this stretch.
In 2030, ODTX is projected to trade between $36.89 and $89.63, averaging $55.25 — a potential gain of +192% from today's $18.93. That is up +16% on the projected 2029 average. Momentum favours further upside here.
Odyssey Therapeutics, Inc.'s 2031 outlook centres on $57.96, within a $37.44 to $96.90 range. That is up +5% on the projected 2030 average. That marks a +206% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ODTX could reach as high as $119.10, with a base case around $69.36 and support toward $43.43 — roughly +266% from $18.93. Momentum favours further upside here.
Expect ODTX to range from $53.68 to $155.33 through 2033. The $88.30 average target implies a +366% move from current prices. That is up +27% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ODTX price prediction for 2034 points to an average of $106.38 (low $62.85, high $191.29) — a potential gain of +462% on today's $18.93. Momentum favours further upside here.
In 2035, ODTX is projected to trade between $72.71 and $232.15, averaging $126.51 — a potential gain of +568% from today's $18.93. That is up +19% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Odyssey Therapeutics, Inc.'s 2040 outlook centres on $204.63, within a $103.26 to $408.27 range. That is up +62% on the projected 2035 average. That marks a +981% change versus current levels. Momentum favours further upside here.
By 2050, ODTX could reach as high as $1,039.86, with a base case around $462.81 and support toward $208.27 — roughly +23.4x from $18.93. Buyers look set to stay in control over this stretch.
Investing $1,000 in ODTX today (≈ 52.826202 ODTX) could be worth
$24,448.66
+$23,448.66 (+2345%) by 2050 · US Dollar
Based on the average projected ODTX price of $462.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ODTXwould be worth at today's price.
$1,000 invested in ODTX on May 8, 2026 (≈ 60.90134 ODTX) would be worth
$1,152.86
+$152.86 (+15.3%) today · 1.15× · US Dollar
Based on a ODTX entry price of $16.42 vs. today's $18.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.66 | $1,014.47 | +1.4% |
| 1 month ago | $16.61 | $1,139.67 | +14.0% |
| All time ago | $16.42 | $1,152.86 | +15.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ODTX forecast.
Our base-case forecast reaches $38.00 around 2028.
Implied market cap at $38.00: $1.83B
The multi-year forecast shows substantial upside potential. In 2026 the avg price is $18.22 with a min of $15.56, a max of $28.35 and an ROI of 0 (sentiment NEUTRAL). From 2027 onward, the path turns more bullish, with 2027 avg $29.79 and 2028 avg $39.06, rising further to 2030 avg $53.30 with an ROI of 192.6 and a bullish sentiment.
By 2031–2035 the forecast continues to climb (2031 avg $56.93, 2032 $67.05, 2033 $85.32, 2034 $104.39, 2035 $122.76) and the longer horizon shows continued upside into 2040 (avg $200.60) and 2050 (avg $446.23) with max values of $407.32 in 2040 and $1,022.93 in 2050 and ROI figures of 1001 and 2349.1 respectively, all with bullish sentiment.
Tap a question to reveal the answer.
Avg $53.30; Min $35.11; Max $87.57; ROI 192.6; Sentiment BULLISH.
The forecast shows a bullish trajectory after 2026, with increasing averages (e.g., 2027 avg $29.79, 2028 avg $39.06, 2029 avg $46.48, 2030 avg $53.30) and rising ROI (e.g., 63.5% in 2027, 114.4% in 2028, 155.1% in 2029, 192.6% in 2030).
Yes. The max forecast reaches $152.30 in 2033, $190.58 in 2034, $407.32 in 2040, and $1,022.93 in 2050.
Current price is $18.22 and market cap is $875.13M.
RSI 14 days is 60; SMA50 is $17.38; 30-day range is $14.95 to $22.20; support is $15.56 and resistance is $19.07; sentiment is BULLISH.
Odyssey Therapeutics, Inc. Community Discussion
0Share your Odyssey Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.